When Opportunity Knocks: Leveraging Your Expertise to Get Innovations from Bench to Bedside
As the CEO and chair at Neuron23, Dr. Nancy Stagliano takes a hands-on approach to building the company, following the science, and mentoring a team of industry leaders. Dr. Stagliano has a PhD in neuroscience, and degrees in both biomedical and electrical engineering, followed by a postdoc at Harvard Medical School. She holds numerous patents and published works in respected journals, in addition to being CEO of three successful companies—True North Therapeutics, iPierian, and CytomX Therapeutics. In her talk, Dr. Stagliano will share her incredibly successful scientific career journey and engage about key tips and tricks to successfully creating innovations and moving the field of translational medicine and research forward.